Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Bataille

Showing results (261-270 of 322) with videos related to

Pageof 33
Sort By:
British Journal of Haematology|December 1, 1990
Micro-osteoclast resorption as a characteristic feature of B-cell malignancies other than multiple myelomaJ F Rossi, D Chappard, C Marcelli, et al.
Clinical Immunology and Immunopathology|March 1, 1991
Autoantibodies in D-penicillamine-induced myasthenia gravis: a comparison with idiopathic myasthenia and rheumatoid arthritisE Morel, M N Feuillet-Fieux, B Vernet-der Garabedian, et al.
Leukemia|August 30, 2002
Large deletions 5' to the ETO breakpoint are recurrent events in patients with t(8;21) acute myeloid leukemiaC Godon, J Proffitt, N Dastugue, et al.
Chemical Communications (Cambridge, England)|October 29, 2008
Enantiomerically pure bicyclo[3.3.1]nona-2,6-diene as the sole source of enantioselectivity in BIPHEP-Rh asymmetric hydrogenationTharmalingam Punniyamurthy, Monika Mayr, Alexander S Dorofeev, et al.
Leukemia|March 23, 1999
Lack of efficacy of clarithromycin in advanced multiple myeloma. Intergroupe Français du Myélome (IFM)P Moreau, A Huynh, T Facon, et al.
Leukemia|February 20, 1999
Differential expression of Bcl-2 in human plasma cell disorders according to proliferation status and malignancyD Puthier, C Pellat-Deceunynck, S Barillé, et al.
Journal of Medicinal Chemistry|December 26, 2023
Development of Highly Potent, G-Protein Pathway Biased, Selective, and Orally Bioavailable GPR84 AgonistsPinqi Wang, Arun Raja, Vincent B Luscombe, et al.
Leukemia|May 20, 2005
Mcl-1 is overexpressed in multiple myeloma and associated with relapse and shorter survivalS Wuillème-Toumi, N Robillard, P Gomez, et al.
Molecular Cell|January 31, 2012
A universal RNA polymerase II CTD cycle is orchestrated by complex interplays between kinase, phosphatase, and isomerase enzymes along genesAlain R Bataille, Célia Jeronimo, Pierre-Étienne Jacques, et al.
Beilstein Journal of Organic Chemistry|June 20, 2020
Anthelmintic drug discovery: target identification, screening methods and the role of open scienceFrederick A Partridge, Ruth Forman, Carole J R Bataille, et al.
Pageof 33

Showing results (261-270 of 322) with videos related to

Sort By:
Pageof 33
British Journal of Haematology|December 1, 1990
Micro-osteoclast resorption as a characteristic feature of B-cell malignancies other than multiple myelomaJ F Rossi, D Chappard, C Marcelli, et al.
Clinical Immunology and Immunopathology|March 1, 1991
Autoantibodies in D-penicillamine-induced myasthenia gravis: a comparison with idiopathic myasthenia and rheumatoid arthritisE Morel, M N Feuillet-Fieux, B Vernet-der Garabedian, et al.
Leukemia|August 30, 2002
Large deletions 5' to the ETO breakpoint are recurrent events in patients with t(8;21) acute myeloid leukemiaC Godon, J Proffitt, N Dastugue, et al.
Chemical Communications (Cambridge, England)|October 29, 2008
Enantiomerically pure bicyclo[3.3.1]nona-2,6-diene as the sole source of enantioselectivity in BIPHEP-Rh asymmetric hydrogenationTharmalingam Punniyamurthy, Monika Mayr, Alexander S Dorofeev, et al.
Leukemia|March 23, 1999
Lack of efficacy of clarithromycin in advanced multiple myeloma. Intergroupe Français du Myélome (IFM)P Moreau, A Huynh, T Facon, et al.
Leukemia|February 20, 1999
Differential expression of Bcl-2 in human plasma cell disorders according to proliferation status and malignancyD Puthier, C Pellat-Deceunynck, S Barillé, et al.
Journal of Medicinal Chemistry|December 26, 2023
Development of Highly Potent, G-Protein Pathway Biased, Selective, and Orally Bioavailable GPR84 AgonistsPinqi Wang, Arun Raja, Vincent B Luscombe, et al.
Leukemia|May 20, 2005
Mcl-1 is overexpressed in multiple myeloma and associated with relapse and shorter survivalS Wuillème-Toumi, N Robillard, P Gomez, et al.
Molecular Cell|January 31, 2012
A universal RNA polymerase II CTD cycle is orchestrated by complex interplays between kinase, phosphatase, and isomerase enzymes along genesAlain R Bataille, Célia Jeronimo, Pierre-Étienne Jacques, et al.
Beilstein Journal of Organic Chemistry|June 20, 2020
Anthelmintic drug discovery: target identification, screening methods and the role of open scienceFrederick A Partridge, Ruth Forman, Carole J R Bataille, et al.
Pageof 33